Matches in Nanopublications for { ?s ?p "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP818747.RAdfpXYXuZX01Y1Zj4Ji9DNcpw1pzcb0HkBLIMuZtALxI130_assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818747.RAdfpXYXuZX01Y1Zj4Ji9DNcpw1pzcb0HkBLIMuZtALxI130_provenance.
- assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1116536.RAapM8tV1tWB4khTc-AW5ap61DOIjHxPS1bwEZKLKsZi8130_assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116536.RAapM8tV1tWB4khTc-AW5ap61DOIjHxPS1bwEZKLKsZi8130_provenance.
- NP792594.RABQOsz3qR2__DfCMYDlBkWHxnCASbL3FBlvj44IQbSpo130_assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792594.RABQOsz3qR2__DfCMYDlBkWHxnCASbL3FBlvj44IQbSpo130_provenance.
- NP1116535.RANFPMOn9iU-Znlu0cMG4CR29BkF1psaz1KeA7P7NmPUc130_assertion description "[On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116535.RANFPMOn9iU-Znlu0cMG4CR29BkF1psaz1KeA7P7NmPUc130_provenance.